Displaying 21 - 24 of 24
The Collings Stevens Family Foundation partners with LLSC to help Canadians impacted by CML
Updated:
The Leukemia & Lymphoma Society of Canada, with partners like The Collings Stevens Family Foundation, is informing and empowering people impacted by chronic myeloid leukemia (CML), a once-fatal blood cancer now a manageable disease.
Partners, Leukemia
New AI research award recipient supported by UFCW
Updated:
One of the exciting, novel aspects of LLSC’s latest blood cancer research awards is the introduction of the Artificial Intelligence (AI) Catalyst Grant, for the application of AI to blood cancer research.
Partners, Research
Precision medicine, chemotherapy alternatives, and zebrafish genes
Updated:
Canadian researchers exploring precision medicine with immunotherapy have received a total of $600,000 from the Leukemia and Lymphoma Society of Canada (LLSC) for pediatric blood cancer research innovation.
Partners, Pediatrics, Research
Insights from BioCanRX Summit for Cancer Immunotherapy 2023
Updated:
I just got back from the 2023 BioCanRX Summit4ci that was held in Ottawa October 1-4 and I want to share a few of the amazing highlights that have come out of the conference this year.
Partners, Research, Events